• 114 Citations
  • 3 h-Index
If you made any changes in Pure these will be visible here soon.

Personal profile


After some years working as a community pharmacist, I came to Macquarie University to do a PhD in Pharmacology. I finished my PhD in 2015, where I researched the effect of single nucleotide polymorphisms and phosphomutation of the mu-opioid receptor.

After concluding my PhD, I started working for Prof. Mark Connor and the Lambert Initiative for Cannabinoid Therapeutics. The project focus in the creation of platforms for the cell based elucidation of potential cannabinoid mechanisms of action in epilepsies.

Now I am engaged in teaching pharmacology, research and professional practice, in addition to continue researching molecular pharmacology of cannabinoids and opioids.

External positions

Liaison Pharmacist , Nepean Blue Mountains Local Health District

Jul 2016Jan 2017

Community Pharmacist, Dee Why Grand Pharmacy

May 2011Jun 2016

Fingerprint Dive into the research topics where Marina Junqueira Santiago is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
mu Opioid Receptor Medicine & Life Sciences
Opioid Analgesics Medicine & Life Sciences
Buprenorphine Medicine & Life Sciences
Cannabinoid Receptor Agonists Medicine & Life Sciences
Cannabinoid Receptors Medicine & Life Sciences
Cannabinoids Medicine & Life Sciences
Cannabis Medicine & Life Sciences
Terpenes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Outputs 2013 2019

  • 114 Citations
  • 3 h-Index
  • 7 Article
Open Access
Cannabinoid Receptors
Potassium Channels

Cannabichromene is a Cannabinoid CB2 receptor agonist

Udoh, M., Santiago, M., Devenish, S., McGregor, I. & Connor, M., 1 Aug 2019, (Accepted/In press) In : British Journal of Pharmacology.

Research output: Contribution to journalArticleResearchpeer-review

Cannabinoid Receptor Agonists
Cannabinoid Receptor CB2
Cannabinoid Receptor CB1
Cell Surface Receptors

Development of bright and biocompatible nanoruby and its application to background-free time-gated imaging of G-protein-coupled receptors

Sreenivasan, V. K. A., Wan Razali, W. A., Zhang, K., Pillai, R. R., Saini, A., Denkova, D., Santiago, M., Brown, H., Thompson, J., Connor, M., Goldys, E. M. & Zvyagin, A. V., 15 Nov 2017, In : ACS Applied Materials and Interfaces. 9, 45, p. 39197-39208 12 p.

Research output: Contribution to journalArticleResearchpeer-review

G-Protein-Coupled Receptors
Imaging techniques
mu Opioid Receptor

Pharmacology of valinate and tert-leucinate synthetic cannabinoids 5f-ambica, 5f-amb, 5f-adb, amb-fubinaca, mdmb-fubinaca, mdmb-chmica, and their analogues

Banister, S. D., Longworth, M., Kevin, R., Sachdev, S., Santiago, M., Stuart, J., Mack, J. B. C., Glass, M., McGregor, I. S., Connor, M. & Kassiou, M., 21 Sep 2016, In : ACS Chemical Neuroscience. 7, 9, p. 1241-1254 14 p.

Research output: Contribution to journalArticleResearchpeer-review


A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro

Knapman, A., Santiago, M. & Connor, M., 5 Jan 2015, In : British Journal of Pharmacology. 172, 9, p. 2258-2272 15 p.

Research output: Contribution to journalArticleResearchpeer-review

mu Opioid Receptor
Opioid Analgesics
CHO Cells

Activities 2015 2017

  • 2 Publication Peer-review
  • 1 Oral presentation

PeerJ (Journal)

Marina Santiago (Reviewer)

Activity: Publication peer-review and editorial workPublication Peer-review

Signalling modification by Single Nucleotide Polymorphisms in the third intracellular loop of the mu-opioid receptor

Marina Junqueira Santiago (Speaker)
8 Dec 2017

Activity: Talk or presentationOral presentation

British Journal of Pharmacology (Journal)

Marina Junqueira Santiago (Reviewer)

Activity: Publication peer-review and editorial workPublication Peer-review